HIV-1 Integrase Multimerization as a Therapeutic Target
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Multimeric HIV-1 integrase (IN) plays an essential, multifunctional role in virus replication and serves as an important therapeutic target. Structural and biochemical studies have revealed the importance of the ordered interplay between IN molecules for its function. In the presence of viral DNA ends, individual IN subunits assemble into a tetramer and form a stable synaptic complex (SSC), which mediates integration of the reverse transcribed HIV-1 genome into chromatin. Cellular chromatin-associated protein LEDGF/p75 engages the IN tetramer in the SSC and directs HIV-1 integration into active genes. A mechanism to deregulate the productive interplay between IN subunits with small molecule inhibitors has recently received considerable attention. Most notably, allosteric IN inhibitors (ALLINIs) have been shown to bind to the IN dimer interface at the LEDGF/p75 binding pocket, stabilize interacting IN subunits, and promote aberrant, higher order IN multimerization. Consequently, these compounds impair formation of the SSC and associated LEDGF/p75-independent IN catalytic activities as well as inhibit LEDGF/p75 binding to the SSC in vitro. However, in infected cells, ALLINIs more potently impaired correct maturation of virus particles than the integration step. ALLINI treatments induced aberrant, higher order IN multimerization in virions and resulted in eccentric, non-infectious virus particles. These studies have suggested that the correctly ordered IN structure is important for virus particle morphogenesis and highlighted IN multimerization as a plausible therapeutic target for developing new inhibitors to enhance treatment options for HIV-1-infected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131 · cited 1×
“Previous HTS efforts using the strand transfer and 3′-processing assays have led to discovery of diketo acid-based INSTIs and quinoline-based ALLINIs (Hazuda et al. 2000; Fader et al. 2014b).”
BackgroundDyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R. (1994) · Science · doi:10.1126/science.7801124 · Cited by 810 · cited 5×
“The CCD–CCD interactions are conserved in the CCD only structures (Dyda et al. 1994; Jenkins et al. 1995; Bujacz et al. 1996; Goldgur et al. 1998; Maignan et al. 1998) as well as in the both two domain NTD–CCD and CCD– CTD structures (Wang et al. 2001; Chen et al. 2000).”
BackgroundInfluentialHIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704 · cited 1×
“…in the preintegration complex (PIC), which in addition to the intasome contains additional viral and cellular proteins, to target HIV-1 integration into active genes (Cherepanov et al. 2003, 2005a; Ciuffi et al. 2005; Llano et al. 2006; Shun et al. 2007; Ferris et al. 2010; Busschots et al. 2005).”
BackgroundRetroviral intasome assembly and inhibition of DNA strand transfer
Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature08784 · Cited by 678 · cited 2×
“…the structural organization of the IN subunits in the SSC emerged from the breakthrough crystal structures of prototype foamy virus (PFV) intasome [(Hare et al. 2010a, b, 2012; Maertens et al. 2010), reviewed in (Cherepanov 2010; Li et al. 2011; Cherepanov et al. 2011; Engelman and Cherepanov…”
BackgroundA role for LEDGF/p75 in targeting HIV DNA integration
Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J. R., & Bushman, F. (2005) · Nature Medicine · doi:10.1038/nm1329 · Cited by 658 · cited 2×
“…in the preintegration complex (PIC), which in addition to the intasome contains additional viral and cellular proteins, to target HIV-1 integration into active genes (Cherepanov et al. 2003, 2005a; Ciuffi et al. 2005; Llano et al. 2006; Shun et al. 2007; Ferris et al. 2010; Busschots et al. 2005).”
BackgroundAn essential role for LEDGF/p75 in HIV integration
Llano, M., Saenz, D. T., Meehan, A., Wongthida, P., Peretz, M., Walker, W. H., Teo, W., & Poeschla, E. M. (2006) · Science · doi:10.1126/science.1132319 · Cited by 537
Engelman, A., & Craigie, R. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6361-6369.1992 · Cited by 519 · cited 2×
“NTD residues His12, His16, Cys40, and Cys43 coordinate a Zn cation which is essential for the ordered structure of this domain as well as the functional multimerization of the fulllength IN (Zheng et al. 1996; Cai et al. 1997; Bushman et al. 1993; Lee et al. 1997; Engelman and Craigie 1992; Hare et al. 2009a).”
BackgroundChrist, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., Bardiot, D., Van der Veken, N. J., Van Remoortel, B., Strelkov, S. V., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.370 · Cited by 479
Shun, M.-C., Raghavendra, N. K., Vandegraaff, N., Daigle, J. E., Hughes, S., Kellam, P., Cherepanov, P., & Engelman, A. (2007) · Genes & Development · doi:10.1101/gad.1565107 · Cited by 467 · cited 3×
“…in the preintegration complex (PIC), which in addition to the intasome contains additional viral and cellular proteins, to target HIV-1 integration into active genes (Cherepanov et al. 2003, 2005a; Ciuffi et al. 2005; Llano et al. 2006; Shun et al. 2007; Ferris et al. 2010; Busschots et al. 2005).”
BackgroundMultiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication
Engelman, A., Englund, G., Orenstein, J. M., Martin, M. A., & Craigie, R. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2729-2736.1995 · Cited by 445
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
Cherepanov, P., Ambrosio, A. L. B., Rahman, S., Ellenberger, T., & Engelman, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506924102 · Cited by 408
Chen, J. C.-H., Krucinski, J., Miercke, L. J. W., Finer-Moore, J. S., Tang, A. H., Leavitt, A. D., & Stroud, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150220297 · Cited by 404 · cited 11×
“Collectively, these findings suggest that ALLINI binding to the CCD–CCD dimer interface triggers additional CTD–CTD and/or CCD–CTD interactions, which are not seen in the functional SSC complex (Fig.”
BackgroundMethodInfluentialSolution structure of the N-terminal zinc binding domain of HIV-1 integrase
Cai, M., Zheng, R., Caffrey, M., Craigie, R., Clore, G. M., & Gronenborn, A. M. (1997) · Nature Structural Biology · doi:10.1038/nsb0797-567 · Cited by 342
Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010246107 · Cited by 305
Llano, M., Vanegas, M., Fregoso, O., Saenz, D., Chung, S., Peretz, M., & Poeschla, E. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9524-9537.2004 · Cited by 305 · cited 1×
“LEDGF/p75 is a predominantly nuclear protein, but it has been suggested that low amounts of the cytoplasmic protein could interact with HIV-1 IN (Llano et al. 2004).”
BackgroundSolution Structure of the DNA Binding Domain of HIV-1 Integrase
Lodi, P. J., Ernst, J. A., Kuszewski, J., Hickman, A. B., Engelman, A., Craigie, R., Clore, G. M., & Gronenborn, A. M. (1995) · Biochemistry · doi:10.1021/bi00031a002 · Cited by 300 · cited 3×
“NMR structures of IN NTD (1–47) (Cai et al. 1997) and a C-terminally truncation IN CTD (220–270) (Lodi et al. 1995; Eijkelenboom et al. 1995, 1999) revealed dimeric organizations for each of the domains.”
BackgroundThe mechanism of retroviral integration from X-ray structures of its key intermediates
Maertens, G. N., Hare, S., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature09517 · Cited by 296 · cited 2×
“…of the IN subunits in the SSC emerged from the breakthrough crystal structures of prototype foamy virus (PFV) intasome [(Hare et al. 2010a, b, 2012; Maertens et al. 2010), reviewed in (Cherepanov 2010; Li et al. 2011; Cherepanov et al. 2011; Engelman and Cherepanov 2012; Krishnan and Engelman…”
BackgroundCherepanov, P., Devroe, E., Silver, P. A., & Engelman, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406307200 · Cited by 287
Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75
Cherepanov, P., Sun, Z.-Y. J., Rahman, S., Maertens, G., Wagner, G., & Engelman, A. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb937 · Cited by 235 · cited 6×
“The X-ray structure for an archetypal ALLINI BI-1001 bound to IN CCD shows that the interactions with subunit 1 are mediated through a hydrogen bonding network between the critical pharmacophore carboxylic acid and IN residues Glu170 and His171acid as well as between the metoxy group and Thr174 side chain (Kessl et al…”
BackgroundInfluentialThe Interaction of LEDGF/p75 with Integrase Is Lentivirus-specific and Promotes DNA Binding
Busschots, K., Vercammen, J., Emiliani, S., Benarous, R., Engelborghs, Y., Christ, F., & Debyser, Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411681200 · Cited by 208
Jurado, K. A., Wang, H., Slaughter, A., Feng, L., Kessl, J. J., Koh, Y., Wang, W., Ballandras-Colas, A., Patel, P. A., Fuchs, J. R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300703110 · Cited by 203
Self-citationDiscovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1
Fader, L. D., Malenfant, E., Parisien, M., Carson, R., Bilodeau, F., Landry, S., Pesant, M., Brochu, C., Morin, S., Chabot, C., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500002n · Cited by 178
In Vivo Analysis of Retroviral Integrase Structure and Function
Engelman, A. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60309-7 · Cited by 176 · cited 3×
“Intriguingly, the observed phenotype following ALLINI treatment is closely reminiscent with the particle maturation defects observed with some class II IN mutants (Engelman et al. 1995; Engelman 1999, 2011; Johnson et al. 2013; Jurado et al. 2013).”
BackgroundCherepanov, P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl885 · Cited by 173
New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
Tsiang, M., Jones, G. S., Niedziela-Majka, A., Kan, E., Lansdon, E. B., Huang, W., Hung, M., Samuel, D., Novikov, N., Xu, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347534 · Cited by 167 · cited 14×
“The X-ray structure for an archetypal ALLINI BI-1001 bound to IN CCD shows that the interactions with subunit 1 are mediated through a hydrogen bonding network between the critical pharmacophore carboxylic acid and IN residues Glu170 and His171acid as well as between the metoxy group and Thr174 side chain (Kessl et al…”
BackgroundMethodResultInfluentialHare, S., Shun, M.-C., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000259 · Cited by 166 · cited 7×
“While each tetramer was stabilized by identical intermolecular NTD and CCD–CCD dimer interactions with LEDGF/IBD, the relative positioning and orientations of interacting dimers varied significantly which indicates that there is a high degree of plasticity for IN tetramerization (Hare et al. 2009a).”
BackgroundResultInfluential3′‐Processing and strand transfer catalysed by retroviral integrase in crystallo
Hare, S., Maertens, G. N., & Cherepanov, P. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.118 · Cited by 153
LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions
Desimmie, B. A., Schrijvers, R., Demeulemeester, J., Borrenberghs, D., Weydert, C., Thys, W., Vets, S., Van Remoortel, B., Hofkens, J., De Rijck, J., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-57 · Cited by 139
Le Rouzic, E., Bonnard, D., Chasset, S., Bruneau, J.-M., Chevreuil, F., Le Strat, F., Nguyen, J., Beauvoir, R., Amadori, C., Brias, J., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-144 · Cited by 127
Balakrishnan, M., Yant, S. R., Tsai, L., O’Sullivan, C., Bam, R. A., Tsai, A., Niedziela-Majka, A., Stray, K. M., Sakowicz, R., & Cihlar, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074163 · Cited by 126 · cited 9×
“Substitutions in HIV-1 IN that conferred resistance to ALLINIs were able to overcome these defects (Balakrishnan et al. 2013; Jurado et al. 2013; Feng et al. 2013) indicating that these inhibitors selectively targeted IN during particle morphogenesis.”
BackgroundInfluentialA New Class of Multimerization Selective Inhibitors of HIV-1 Integrase
Sharma, A., Slaughter, A., Jena, N., Feng, L., Kessl, J. J., Fadel, H. J., Malani, N., Male, F., Wu, L., Poeschla, E., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004171 · Cited by 124 · cited 10×
“For example, replacing the rigid quinolone moiety with a more flexible pyridine-based structure in KF166 avoided the marked A128T resistance seen for quinolonebased ALLINIs (Sharma et al. 2014).”
BackgroundSelf-citationStructural Basis for Functional Tetramerization of Lentiviral Integrase
Hare, S., Di Nunzio, F., Labeja, A., Wang, J., Engelman, A., & Cherepanov, P. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000515 · Cited by 122
Allosteric Inhibition of Human Immunodeficiency Virus Integrase
Gupta, K., Brady, T., Dyer, B. M., Malani, N., Hwang, Y., Male, F., Nolte, R. T., Wang, L., Velthuisen, E., Jeffrey, J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551119 · Cited by 81 · cited 4×
“In contrast, therapeutically relevant concentrations of ALLINIs had no detectable effects on LEDGF/p75-mediated HIV-1 integration site selectivity (Sharma et al. 2014; Gupta et al. 2014); (ii) Structural, biochemical, and virology experiments have collectively indicated that the A128T IN substitution, that confers mar…”
BackgroundInfluentialAn Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule
Kessl, J. J., Eidahl, J. O., Shkriabai, N., Zhao, Z., McKee, C. J., Hess, S., Burke, T. R., & Kvaratskhelia, M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058883 · Cited by 50 · cited 8×
“For example, a small molecule N,O-bis(3,4,-diacetyloxycinnamoyl)-serinate [referred in (Kessl et al. 2009) and here as compound 1] has been shown to bind at the IN dimer interface and stabilize interacting subunits into an inactive multimeric form Kessl et al.”
BackgroundMethodInfluentialSelf-citationShkriabai, N., Dharmarajan, V., Slaughter, A., Kessl, J. J., Larue, R. C., Feng, L., Fuchs, J. R., Griffin, P. R., & Kvaratskhelia, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589572 · Cited by 30 · cited 2×
“Mass spectrometry-based protein footprinting of full-length IN in complex with ALLINI has identified protein–protein interactions in the CCD and CTD that extend beyond the inhibitor-binding site and which contribute to higher order IN multimerization (Shkriabai et al. 2014).”
BackgroundSelf-citationDU, L., ZHAO, Y.-X., YANG, L.-M., ZHENG, Y.-T., TANG, Y., SHEN, X., & JIANG, H.-L. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00863.x · Cited by 22
Cited by
Peese, K. M., Allard, C. W., Connolly, T., Johnson, B. L., Li, C., Patel, M., Sorensen, M. E., Walker, M. A., Meanwell, N. A., McAuliffe, B., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01473 · Cited by 39
Deng, N., Hoyte, A., Mansour, Y. E., Mohamed, M. S., Fuchs, J. R., Engelman, A. N., Kvaratskhelia, M., & Levy, R. (2016) · Protein Science · doi:10.1002/pro.2997 · Cited by 36
Self-citationFeng, L., Dharmarajan, V., Serrao, E., Hoyte, A., Larue, R. C., Slaughter, A., Sharma, A., Plumb, M. R., Kessl, J. J., Fuchs, J. R., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00167 · Cited by 37
Self-citation
Metadata
- Authors
- Feng, L., Larue, R. C., Slaughter, A., Kessl, J. J., & Kvaratskhelia, M.
- Venue
- Current Topics in Microbiology and Immunology
- Publisher
- Springer International Publishing
- Published
- 2015
- Volume
- 389
- Pages
- 93-119
- ISSN
- 0070-217X (ISSN-L)
- 2196-9965
- OpenAlex
- W1827743573
- Cited by
- 45
- References
- 36
- FWCI
- 25.50
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.